Premium
Can glycans unveil the origin of glycoprotein hormones?—human chorionic gonadotrophin as an example—
Author(s) -
RamírezLlanelis R.,
Llop E.,
Ventura R.,
Segura J.,
GutiérrezGallego R.
Publication year - 2008
Publication title -
journal of mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 121
eISSN - 1096-9888
pISSN - 1076-5174
DOI - 10.1002/jms.1448
Subject(s) - recombinant dna , glycomics , chemistry , glycoprotein , glycan , glycosylation , hormone , neuraminic acid , sialic acid , protein subunit , biochemistry , gene
Abstract Doping with (glyco)protein hormones represent an extremely challenging, analytical problem as nearly all are constitutively present at low concentrations that fluctuate according to circadian or alternative periodical, or external stimuli. Thus the mere concentration in a biological sample is only resolutive when this surpasses extreme values. As the vast majority of these molecules are produced by recombinant DNA technology it is believed that the exogenous molecules could bear the signature of the host cell. In particular, these could comprise structural differences originated from co or post‐translational differences. In this study we have employed both proteomics and glycomics strategies to compare recombinant and urinary human chorionic gonadotrophin in order to evaluate this hypothesis. As anticipated the recombinant hormone could be shown to contain N ‐glycolyl neuraminic acid, a sialic acid that cannot be produced by humans. Furthermore, differences were observed in the overall glycosylation, in particular the presence of abundant hybrid‐type glycans that were much less pronounced in the recombinant species. These differences were determined to occur predominantly in the α‐subunit for which antidoping strategies focussed on these elements could be used for both chorionic gonadotrophin and lutrophin as they share the same α‐subunit. Copyright © 2008 John Wiley & Sons, Ltd.